From Ozempic to Wegovy to Mounjaro, injectable weight-loss drugs have become household names — and now there’s a new one ...

Though it hasn't even wrapped up clinical trials, the weight loss drug retatrutide already has a cult following.

Eli Lilly announced trial results for its weight-loss medication, orforglipron, in August. Orforglipron is a once-daily oral GLP-1 pill being studied for the treatment of type 2 diabetes and obesity, ...

An advert which targeted weight-loss injections at new mums has been banned by the Advertising Standards Authority (ASA). MedExpress's social media post used a harmful gender stereotype which ...

Retatrutide, originally developed by Eli Lilly, has found a loyal fan base—even though clinical trials of the drug still ...

Weight Watchers has launched a new service to help people using GLP-1 medications like Ozempic or Wegovy keep the weight off.

Tirzepatide, used in Mounjaro and Zepbound, can produce dramatic weight loss and improvements in blood pressure, cholesterol ...

For more than two years it had the entirety of the market for weight-loss drugs to itself. By 2023 sales of Wegovy had ...

Researchers say new compound improves metabolic activity within muscles instead of acting on hunger pathways like Ozempic and ...

The Advertising Standards Authority, known as the ASA, has banned three social media adverts linked to prescription weight loss injections. The rulings cover MedExpress, CheqUp and WLO Ltd trading as ...

Australia’s drug regulator, Therapeutic Goods Administration, has issued a new safety warning for Ozempic and similar weight-loss and diabetes drugs, citing possible links to suicidal thoughts and ...